Literature DB >> 2425868

Coagulation-cancer interaction in situ in renal cell carcinoma.

L R Zacharski, V A Memoli, S M Rousseau.   

Abstract

Fibrin was detected by immunospecific techniques associated with both intravascular and extravascular tumor deposits in renal cell carcinoma. In addition, coagulation factors VII and X were demonstrated in intercellular spaces within tumor tissue and adjacent to the surface of tumor cells. Scant accumulation of platelets on intravascular tumor masses was observed. These data suggest that tumor cells in renal cell carcinoma may induce fibrin formation locally by a factor VII-mediated (and thus tissue factor-initiated) pathway of blood coagulation. This mechanism may also account for the hypercoagulable state that exists with this tumor type. We postulate that local fibrin formation may contribute to the growth and spread of this particular type of cancer and that the course of renal cell carcinoma may be ameliorated by anticoagulant therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2425868

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Procoagulant activity of gastric, colorectal, and renal cancer is factor VII-dependent.

Authors:  M Szczepański; K Bardadin; J Zawadzki; W Pypno
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 2.  Platelet--cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation.

Authors:  Paul Jurasz; David Alonso-Escolano; Marek W Radomski
Journal:  Br J Pharmacol       Date:  2004-10-18       Impact factor: 8.739

3.  Blood transfusion and surgery: the effect on growth of a syngeneic sarcoma.

Authors:  N R Parrott; T W Lennard; G Proud; B K Shenton; A Givan; M D White; R Taylor
Journal:  Ann R Coll Surg Engl       Date:  1990-03       Impact factor: 1.891

Review 4.  Tissue factor as a tumor procoagulant.

Authors:  L V Rao
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

Review 5.  The role of fibrin in tumor metastasis.

Authors:  V Costantini; L R Zacharski
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

6.  Do circulating tumor cells play a role in coagulation and thrombosis?

Authors:  Garth W Tormoen; Kristina M Haley; Ross L Levine; Owen J T McCarty
Journal:  Front Oncol       Date:  2012-09-10       Impact factor: 6.244

7.  A novel fragment derived from the beta chain of human fibrinogen, beta43-63, is a potent inhibitor of activated endothelial cells in vitro and in vivo.

Authors:  E Krajewska; C E Lewis; Y-Y Chen; A Welford; S Tazzyman; C A Staton
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

8.  Procoagulant activity may be a marker of the malignant phenotype in experimental prostate cancer.

Authors:  A S Adamson; P Luckert; M Pollard; M E Snell; M Amirkhosravi; J L Francis
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

9.  Fibrinogen-derived fibrinostatin inhibits tumor growth through anti-angiogenesis.

Authors:  Chuanke Zhao; Yahui Su; Jianzhi Zhang; Qin Feng; Like Qu; Lixin Wang; Caiyun Liu; Beihai Jiang; Lin Meng; Chengchao Shou
Journal:  Cancer Sci       Date:  2015-10-16       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.